Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan

Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan

Abstract Tyrosine kinase inhibitors (TKIs) improve the prognosis of patients with gastrointestinal stromal tumors (GISTs). We conducted a retrospective cohort study using cancer registries linked with health utilization data in Japan and Taiwan to assess TKI usage in older and non-older patients. Pa...

Full description

Bibliographic Details
Main Authors: Yuichi Ichinose, Yi-Hsin Yang, Hui-Jen Tsai, Ru-Yu Huang, Takahiro Higashi, Toshirou Nishida, Li-Tzong Chen
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-27092-z

Internet

https://doi.org/10.1038/s41598-022-27092-z

Similar Items